Searchable abstracts of presentations at key conferences in endocrinology

ea0005oc26 | Brain and Behaviour | BES2003

11beta-Hydroxysteroid dehydrogenase type 2 (11beta-HSD2), a protector of the developing brain

Holmes M , Sangra M , Seckl J

Glucocorticoids have profound effects in development, altering cell proliferation, differentiation, migration and network formation. It has been shown that the developing fetus is protected from high maternal glucocorticoid levels by the presence of 11beta-HSD2 in the placenta and if this enzyme is inhibited, programmed changes of adult health are observed (hypertension, hyperglycaemia, insulin resistance). The developing brain is a sensitive target for glucocorticoids and hen...

ea0077lb16 | Late Breaking | SFEBES2021

Management of hypoglycemia in hospitalized patients with diabetes

Rathi Kiran , Holmes Laura , Hassan Reem , Anand Haridass Sabari

Aim: To determine if inpatient hypoglycemia management in our trust is compliant with NICE guidelines and understand the conundrums in documentation and treatment of the hypoglycemic episodes.Method: Retrospective audit on all patients admitted in Huddersfield Royal Infirmary who had hypoglycemic episode(s) in March 2021 which were picked up by wireless-enabled central capillary blood glucose monitoring system (cobas)1.R...

ea0053cd1.1 | Case Discussions: complex clinical cases 1.0 | OU2018

A novel way to manage obesity in a patient with poorly controlled Addison’s disease

Rajeswaran Chinnadorai , Holmes Simon , Joseph Vinod , Hanafy Ahmed

Introduction: The reason for weight gain is multifactorial. Effective intervention can only be incorporated if the underlying cause is evaluated correctly. Here we present a lady with Addison’s disease who gain significant weight and was helped to lose weight using a novel approach.Case-Report: 42 year-old lady was referred to our weight-management service as she was unsuccessful in losing weight. Detailed evaluation in the obesity clinic revealed t...

ea0063p406 | Thyroid 1 | ECE2019

Exacerbation of thyrotoxicosis following radioiodine therapy in benign thyroid diseases: can it be predicted?

Hanafy Ahmed , Holmes Simon , Britton Jason , Pereira Olivia

Introduction: Radioactive iodine (RAI) is an effective and widely used treatment for thyrotoxicosis. Post-radioiodine thyrotoxicosis is a well-known side effect of RAI. This is usually mild and easily controlled mostly with beta blockers but sometimes needs anti-thyroid drugs (ATD).Aim of the study: To assess the incidence and predictors of post-radioiodine thyrotoxicosis.Methods: Retrospective analysis of 86 patients who had RAI t...

ea0038fp6 | (1) | SFEBES2015

The role of 11β-hydroxysteroid dehydrogenase type 2 in the central regulation of blood pressure and salt appetite

McNairn Julie , Bailey Matthew , Moran Carmel , Work Lorraine , Holmes Megan

Increased intake of sodium is postulated to be controlled by aldosterone-sensitive cells in a select region of the adult mouse brain, the nucleus of the solitary tract (NTS). These cells express the enzyme 11β-hydroxysteroid dehydrogenase type 2 (HSD2) which inactivates glucocorticoids, allowing selective activation of mineralocorticoid receptors by aldosterone. However in the developing brain, HSD2 is widely expressed to protect against adverse glucocorticoid action, whi...

ea0038p196 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Evidence for 11β-HSD1 regulation of brain energy metabolism following systemic inflammation

Verma Manu , Kipari Tiina , Seckl Jonathan , Holmes Megan , Chapman Karen

Background: Chronically elevated brain glucocorticoid (GC) levels impair cognition. In rodents, raised GC levels prior to lipopolyaccharide (LPS) administration potentiate neuroinflammation although GC suppresses neuroinflammation if administered after LPS. 11β-hydroxysteroid dehydrogenase-1 (11β-HSD1) activity can increase intracellular GC levels, including in the brain, without alteration in circulating levels. 11β-HSD1 deficiency/inhibition protects against a...

ea0031p346 | Steroids | SFEBES2013

ACTH independent bilateral macronodular adrenal hyperplasia presenting as subclinical Cushing's syndrome

Thida Myat , Shankaran Vani , Holmes Simon , Rajeswaran C , Srinivasan Bala

Background: Hypercortisol states present a diagnostic conundrum. Other conditions such as cyclical and subclinical Cushings pose additional challenges. We report a complex clinical presentation of thymoma with coexisting subclinical Cushing’s.Case report: A 65-year-old man presented to chest clinic with breathlessness and anterior mediastinal mass on CXR. CT scan demonstrated a 7.5 cm probable thymoma and bilateral adrenal masses of varying sizes up...

ea0031p380 | Thyroid | SFEBES2013

Raised TSH: a diagnostic conundrum!

Mohammad Misbah , Thida Myat , Holmes Simon , Srinivasan Bala T

Background: Elevated TSH with raised free T4 (fT4) presents a diagnostic challenge. Symptomatically they vary across the spectrum of thyroid status. We report cases with these dilemmas.Case 1: Seventy four year old was referred with 5 years of TSH ranging between 4.9–7.9 mIU/l (0.2–4.0), fT4 18.5–27 pmol/l (9.0–19) and free T3 (fT3) 4.5–12 pmol/l (2.5–5.7). Thyroid perox...

ea0028p136 | Growth and development | SFEBES2012

Maturational effects of glucocorticoids on fetal cardiomyocytes are direct and mediated by glucocorticoid receptor

Rog-Zielinska Eva , Kenyon Chris , Holmes Megan , Chapman Karen

In addition to their essential role in fetal lung development, glucocorticoids promote late-gestation maturation of the fetal heart as shown by severe functional impairment, structural disorganisation and transcriptome immaturity in fetal hearts of glucocorticoid receptor-deficient (GR-/-) mice. Here we use primary fetal mouse cardiomyocytes (E16-E17.5) to investigate whether these effects of glucocorticoids result from direct actions of GR and whether they are independent of ...

ea0023oc5.2 | Oral Communications 5 | BSPED2009

Survey on facilities in the local schools for children with type I diabetes (T1D)

Pai Bharathi , Hudson Lizbeth , Holmes Simon , Agwu J Chizo

Introduction: Optimising management of diabetes in school is critical especially with more children being commenced on intensive insulin regimens. Partnership between families, school and caregivers is essential to enhance safety and satisfaction with the educational experience for students.Methodology: We gathered information on facilities in schools for children with T1D from our district hospital by telephonic questionnaire. The questions related to p...